Eli Lilly and Co – Finance Tailwind

Novo Nordisk to buy Akero Therapeutics for up to $5.2 billion

Stocks jump despite shutdown; we bought more of our newest stocks

Paccar, Intel, RH, Riot Platforms and more

Stocks making the biggest moves midday: BA, MIR, PCAR

Roche plans to become top 3 obesity player as CT-388 enters trial

Eli Lilly plans $6.5 billion Texas manufacturing plant for obesity pill

Eli Lilly obesity pill beats Novo Nordisk drug in diabetes trial

Eli Lilly to build $5 billion Virginia manufacturing facility

Pharma firms pile pressure on the UK as Trump’s drug pricing order looms

CPI report health care inflation rises